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Abstract
Elevated systemic hematocrit (Hct) increases cardiovascular risk, such as stroke and
myocardial infarction. One possible pathophysiological mechanism could be a disturbance of
the blood - endothelium interface. It has been shown that blood interacts with the endothelial
surface via a gel-like layer ('glycocalyx', or 'endothelial surface layer - ESL') that modulates
various biological processes, including inflammation, permeability, and atherosclerosis.
However, consequences of an elevated Hct on the functional properties of this interface are
incompletely understood. In a transgenic mouse (tg6) model exhibiting systemic Hct levels of
about 0.85 the glycocalyx/ESL was nearly abolished. The corresponding increase in vessel
diameter had only minor effects on peripheral flow resistance. This suggests that the
pathological effects of elevated Hct may relate stronger to the biological corollaries of a
reduced ESL thickness and alterations of the blood-endothelium interface, than to an increased
flow resistance.
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 NON-TECHNICAL SUMMARY 
 
Elevated systemic hematocrit (Hct) increases cardiovascular risk, such as stroke and myocardial 
infarction. One possible pathophysiological mechanism could be a disturbance of the blood–
endothelium interface. It has been shown that blood interacts with the endothelial surface via a gel-like 
layer (‘glycocalyx’, or ‘endothelial surface layer – ESL’) that modulates various biological processes, 
including inflammation, permeability, and atherosclerosis. However, consequences of an elevated Hct 
on the functional properties of this interface are incompletely understood. In a transgenic mouse (tg6) 
model exhibiting systemic Hct levels of about 0.85 the glycocalyx/ESL was nearly abolished. The 
corresponding increase in vessel diameter had only minor effects on peripheral flow resistance. This 
suggests that the pathological effects of elevated Hct may relate stronger to the biological corollaries 
of a reduced ESL thickness and alterations of the blood–endothelium interface, than to an increased 
flow resistance. 
 
 
 
ABSTRACT 
 
Elevated systemic hematocrit (Hct) increases cardiovascular risk, such as stroke and myocardial 
infarction. One possible pathophysiological mechanism could be a disturbance of the blood–
endothelium interface. It has been shown that blood interacts with the endothelial surface via a thick 
hydrated macromolecular layer (‘glycocalyx’, or ‘endothelial surface layer – ESL’), modulating 
various biological processes, including inflammation, permeability, and atherosclerosis. However, 
consequences of elevated Hct on the functional properties of this interface are incompletely 
understood. Thus, we combined intravital microscopy of an erythropoietin overexpressing transgenic 
mouse line (tg6) with excessive erythrocytosis (Hct 0.85), microviscometric analysis of 
hemodynamics, and a flow simulation model to assess the effects of elevated Hct on glycocalyx/ESL 
thickness and flow resistance. We show that the glycocalyx/ESL is nearly abolished in tg6 mice 
(thickness: wild-type control: 0.52 µm, tg6: 0.13 µm, p<0.001). However, the corresponding reduction 
in network flow resistance contributes < 20% to the maintenance of total peripheral resistance 
observed in tg6 mice. This suggests that the pathological effects of elevated Hct in these mice, and 
possibly also in polycythemic humans, may relate to biological corollaries of a reduced ESL thickness 
and the consequent alteration in the blood–endothelium interface, rather than to an increase of flow 
resistance. 
 
 Abbreviations CFL, cell-free layer; ESL, endothelial surface layer; FL effect, Fåhraeus-Lindqvist 
effect; ηrel, relative apparent viscosity; Hct, hematocrit; HES, hydroxyethyl starch; HR, heart rate; 
MAP, mean arterial pressure; MCV, mean corpuscular volume; µ-PIV, microparticle image 
velocimetry; Rnet, network flow resistance; RBC, red blood cell; tESL, ESL thickness; TPR, total 
peripheral resistance. 
 
 
 
 
 
INTRODUCTION 
 
Many long-term studies on human cohorts have provided evidence that an elevated systemic 
hematocrit (Hct) predisposes the cardiovascular system to ischemic disease. Corresponding events 
such as myocardial infarction, angina pectoris, stroke, and intermittent claudication indicate impaired 
cardiac, cerebral and peripheral perfusion, respectively (Harrison et al., 1981; Gagnon et al., 1994; 
Wannamethee et al., 1994; Brown et al., 2001). Polycythemia vera is a clinical condition that is 
typically associated with an overproduction of red blood cells (RBCs). Patients afflicted with this 
myeloproliferative disorder are also at increased risk for developing arterial and venous 
thromboembolic complications (Spivak, 2002). The precise pathomechanism for this predisposition is 
imperfectly understood. It is generally supposed that the increased cardiovascular risk has its origins in 
pathological alterations in cardiovascular and microvascular hemodynamics, arising from the 
exponential rise in viscosity and the associated increase in blood pressure (Goubali et al., 1995), 
spontaneous platelet aggregation (Lowe & Forbes, 1985), thrombosis (Assaf et al., 2011), and 
impaired left-ventricular function (Schunkert et al., 2000). 
 
In addition, endothelial dysfunction has been shown to be present in polycythemia vera and to be 
correlated with the extent and prognosis of patients at risk of thrombotic disease (Suwaidi et al., 2000; 
Neunteufl et al., 2001). However, beyond its effects on hemodynamics, the possibility that elevated 
hematocrit may lead to pathological alterations of the blood–endothelium interface (Skretteberg et al., 
2010) and that these alterations could be involved in the pathogenesis of vascular disease in 
polycythemia, has not been investigated. 
 
A transgenic mouse line overexpressing the human erythropoietin cDNA (tg6) allows investigation of 
the possible pathophysiological consequences of excessive erythrocytosis (Ruschitzka et al., 2000; 
Vogel & Gassmann, 2011). Due to the antiapoptotic effect of erythropoietin on erythroid progenitor 
cells (Jelkmann, 2011), the systemic Hct in these mice reaches a level of 0.80 to 0.90 within the first 2 
months of life (Wagner et al., 2001). Surprisingly, these animals are viable and show similar levels of 
mean arterial pressure and cardiac output in rest to their wt counterparts, and correspondingly similar 
total peripheral resistance (Wagner et al., 2001). Furthermore, no thromboembolic complications have 
been reported in these mice (Ruschitzka et al., 2000). Apparently, their cardiovascular and 
microvascular systems are able to adjust to the substantial increase in systemic Hct. 
 
One compensatory mechanism for the resistance effects associated with elevated systemic Hct in tg6 
mice could be increased vessel diameter due to augmented synthesis of endothelial nitric oxide 
(Ruschitzka et al., 2000). Another possibility is a reduction in the thickness of the endothelial surface 
layer (ESL), or glycocalyx (Pries et al., 2000) (schematically illustrated on Figure 1B). This blood–
endothelium interface has recently been the subject of increasing attention for its roles in vascular 
physiology and pathophysiology. Various experimental approaches have been taken to estimate the 
thickness and composition of this gel-like layer (Pries et al., 2000; Reitsma et al., 2007). The 
estimated thickness, tESL, of the glycocalyx/ESL in mammals varies between 0.4 and 1.2 µm, 
depending on species, location within the vasculature, and the method used to make the estimate. 
Since plasma flow through the ESL is retarded, the ESL effectively reduces the vascular cross-section 
 available to free-flowing plasma, and directly affects microvascular flow resistance (Pries et al., 1994; 
Pries & Secomb, 2005). 
 
In addition to its influence on microvascular hemodynamics, the blood–endothelium interface also 
affects a number of relevant microvascular mechanisms pertaining to the normal functioning of the 
vascular bed. These range from fluid exchange to inflammatory processes (Vink & Duling, 2000; 
Potter et al., 2009). In this context, a reduction in ESL thickness, though beneficial from a 
hemodynamic perspective, may be detrimental to vascular health. It is evident from experimental 
observations that the vessel walls in tg6 mice are extremely thin and fragile. Microscopic 
investigations have revealed signs of impaired vessel integrity, progressive endothelial inflammation 
and multiple organ degeneration in aged tg6 mice (Heinicke et al., 2006; Ogunshola et al., 2006). This, 
ultimately, may contribute to the substantial reduction in mean life span of tg6 mice compared to wild-
type control littermates, i.e. 7.4 versus 26.7 months (Wagner et al., 2001). Thusfar, however, no study 
has reported on either the possible mechanisms of the putative endothelial degeneration associated 
with excessive erythrocytosis or on the possible effects of Hct changes on the integrity of the blood–
endothelium interface. 
 
The objective of this study is to assess the hemodynamic and hemorheological consequences of strong 
elevations in systemic Hct on the microcirculation, with emphasis placed on the possible effects on the 
blood–endothelium interface, or ESL. Intravital microscopy, microparticle image velocimetry (µ-PIV), 
microviscometric analysis (Damiano et al., 2004), and a hemodynamic network flow simulation were 
employed to study microvascular hemodynamics and the ESL in postcapillary venules in the cremaster 
muscle of tg6 and wild-type mice. In order to discriminate between long-term adaptation to elevated 
hematocrit and sudden hemodynamic changes to an acute reduction in hematocrit, data were collected 
before and after systemic hemodilution in both tg6 and wild-type mice. 
 
 
 
 
MATERIAL AND METHODS 
 
 
Ethical approval 
All procedures were performed after approval by university and governmental committees on animal 
care (Landesamt für Arbeitsschutz, Gesundheitsschutz und technische Sicherheit Berlin, 
Tierversuchsantrag G239/02), and comply with the ethical policies and regulations as outlined in 
Drummond (Drummond, 2009). A total of 44 mice were used in the completion of this study. 
 
Intravital microscopy 
Male tg6 mice (tg, N = 8) and male C57Bl/6 wild-type (wt, N = 8) control littermates, aged 10-20 
weeks, were used in the following groups: tg85 and wt46, with the subscripts referring to the mean 
systemic Hct (expressed as a percentage) of each group. Blood flow was examined by means of 
intravital microscopy (Ernst Leitz, Wetzlar, Germany) in a total of 32 (diameter, D, 40.7 ± 12.2 µm) 
and 37 (D 34.5 ± 8.3 µm) cremaster muscle venules in the tg85 and wt46 groups, respectively. Data was 
collected according to the µ-PIV method, as described in Smith et al. (2003), and the cross-sectional 
velocity distribution of each vessel was extracted from the circulating fluorescent micro-particles (D 
0.5 ± 0.016 µm, FluoSpheres, Molecular Probes, Leiden, The Netherlands) injected via a venous 
catheter and visualized with intermittent stroboscopic flash illumination (Figure 1A). Hemodilution of 
the same animals with hydroxyethyl starch (H) or plasma (p) gave rise to the following groups: tgH46, 
tgp53, wtH30, and wtp24 with a total of 10, 16, 15, and 19 vessels, respectively. The HES and plasma 
groups of the two strains were collected into a single group, denoted by tg50 (D 42.2 ± 12.6 µm) and 
wt27 (D 35.3 ± 8.6 µm), whenever no statistically significant differences were found.  
 
C57Bl/6 wild-type mice were obtained from the ’Forschungseinrichtung Experimentelle Medizin’ 
(FEM) of the Charité Berlin. Tg6 mice, bred by mating hemizygous males to C57Bl/6 females 
(Ruschitzka et al., 2000), were supplied by the Institute of Veterinary Physiology Zurich, Switzerland. 
  
All animals were anesthetized with an intraperitoneal bolus injection of a combination of xylazine (10 
µg/g body weight, bw), ketamine (100 µg/g bw), and atropine (0.1 µg/g bw). Absence of limb 
withdrawal to paw pressure indicated adequacy of anesthesia. After completion of the experimental 
investigation, animals were killed with an overdose of pentobarbital (250 mg/g bw). 
 
Microviscometric analysis 
The µ-PIV data was analyzed according to the microviscometric method recently developed by 
Damiano et al. (2004). This method employs a non-linear regression analysis to determine the velocity 
profile and corresponding ESL thickness that results in the minimum least-squares error in the fit to 
the µ-PIV data. This velocity profile is then used to predict various microvascular flow quantities, 
including the cross-sectional distributions of shear rate, shear stress, and viscosity (supplemental 
Figure S1, red curves), as well as the volumetric flow rate, axial pressure gradient, and relative 
apparent viscosity. Collectively, microviscometric analysis consists of an extensive array of novel 
analytical tools that is capable of predicting local flow and stress within individual microvessels in 
vivo with an accuracy and detail that heretofore were not achievable using traditional methods for 
analyzing flow parameters in the microcirculation.  Microviscometric analysis couples mechanics with 
in vivo measurements of microparticle tracers to analyze vascular functional correlates of changes 
observed after hemodilution in tg6 and wt mice as well as differences observed between tg6 and wt 
mice. These functional correlates include distributions of shear rate, shear stress, velocity and viscosity 
over the vessel cross section of each microvessel analyzed.  Each of these distributions are 
fundamental determinants of vascular function as they dictate flow throughout the microvessel and the 
micromechanical state of stress at the endothelial-cell surface.  These distributions are precisely 
determined in each microvessel that we observed and are functionally correlated across groups (and 
before and after hemodilution within the same group).  
 
Microviscometric analysis has its foundations in continuum mechanics and assumes only that blood 
flow in microvessels >20 microns in diameter can be approximated by the dynamics of a continuous 
homogeneous fluid with spatially varying viscosity; no assumptions about the linearity or nonlinearity 
of blood’s constitutive behavior are necessary.  Support for this continuum approximation was 
provided by Cokelet in his studies using physiological concentrations of red blood cells suspended in 
plasma flowing at physiological shear rates in glass tubes as small as 20 μm in diameter.  Whereas 
empirical curve fitting to µ-PIV data acquired in vivo provides a quantitative, but purely descriptive, 
account of our observations, microviscometric analysis of those µ-PIV data details, in a quantitative 
and predictive manner, full-field distributions that satisfy the conservation principles of mass and 
linear momentum. The accuracy of microviscometric analysis has been substantiated in vivo and in 
glass tube validation studies in vitro (Smith et al., 2003; Long et al., 2004).  Further details of the 
microviscometric analysis used here are provided in the supplemental Methods. 
 
Data on wall shear stress and viscosity for the tg85 group could not be obtained. At very high levels of 
systemic hematocrit, as in the tg6 mice, the analytical technique is not able to properly determine local 
shear stress and apparent viscosity. In order to determine these two quantities, the microviscometric 
method requires a known viscosity at least at one radial position. For normal or low hematocrit levels, 
this condition is met at the virtually cell-free fluid layer adjacent to the vessel wall where plasma 
viscosity is assumed to prevail. For very high hematocrit levels, however, an effectively cell-free layer 
of sufficient width is not observed. Under these conditions, viscosity of the near-wall fluid layers 
might substantially exceed plasma viscosity, and thus neither the radial shear stress distribution nor the 
apparent viscosity can be properly assessed. 
 
A two-phase model of microvascular blood flow was used to estimate the width of a cell-free layer 
(CFL). As illustrated on Figure 1B, this model assumes an instantaneous transition between a core 
region of maximum Hct and a marginal region of zero Hct, termed accordingly RBC-core and CFL, 
respectively. The step distribution assumed by the two-phase flow model is a simplification of the 
non-uniform radial Hct distribution that prevails in microvessels (and which is predicted using 
microviscometric analysis). The width of the CFL derived from the two-phase flow model is an 
indicator of the Hct reduction close to the vessel wall. The ESL is considered as a distinct, nearly 
 quiescent fluid layer that excludes RBCs. This is in contrast to previous studies that use a two-phase 
approach (Maeda et al., 1996; Kim et al., 2007). 
 
Flow simulation model 
In addition, a hemodynamic flow simulation for an experimental vascular network in the rat mesentery 
with 546 vessel segments was used to calculate the overall flow resistance, Rnet (Pries et al., 1994). For 
the vessel lumen available for free fluid flow (D − 2 tESL), a parametric description of apparent 
viscosity in vitro as a function of diameter and systemic Hct (‘in vitro viscosity law’) was used (Pries 
et al., 1992). 
 
An expanded Material and Methods section is available on the J Physiol Web site; see the 
Supplemental Materials link at the top of the online article. 
 
 
 
 
RESULTS 
 
Macrohemodynamic parameters for each experimental group are given in supplemental Table S1. 
Consistent with previous studies (Ruschitzka et al., 2000; Wagner et al., 2001; Vogel et al., 2003), no 
statistically significant difference in baseline MAP was detected between tg6 mice and wt mice. Upon 
hemodilution, MAP declined from 77 to 52 mmHg (p < 0.01) and from 69 to 60mmHg (p > 0.05) in 
tg6 mice and wt mice, respectively. The difference in MAP between the two strains of mice after 
hemodilution was not statistically significant. On the other hand, tg6 mice exhibited a significantly 
higher heart rate (HR) than wt mice, both before (p < 0.05) and after hemodilution (p < 0.001). After 
hemodilution, HR increased from 342 to 525 beats/min in tg6 mice (p < 0.001) and from 261 to 330 
beats/min in wt mice (p < 0.05). These relatively low HR levels (Ruschitzka et al., 2000; Schuler et 
al., 2010) may be due to the depressant cardiovascular effect of the anesthetic regime employed. 
 
As shown in Figure 2A, average flow velocity (vmean) in tg6 mice was 2.6 times lower than in wt mice 
before hemodilution (p < 0.001), and nearly doubled in tg6 mice after hemodilution (p < 0.001). In wt 
mice, hemodilution led to only a minor increase in vmean which was not statistically significant (p > 
0.05). Similarly, centerline flow velocity (vmax) was significantly lower (2.9 times) in tg6 mice as 
compared to wt mice (p < 0.001). Hemodilution resulted in a 96% increase of vmax in tg6 mice (p < 
0.001), but no significant change in wt mice. Blood flow rate in tg6 mice was 52% lower compared 
with wt control values (p < 0.05), and increased to wt levels after hemodilution (supplemental Table 
S2). This corroborates data reported for the tg6 brain where cerebral blood flow was 44% lower 
compared with wt values (Frietsch et al., 2007b). 
 
The velocity profiles of the tg85 group exhibited the lowest ratio of vmax/vmean, and hence the greatest 
degree of bluntness, while groups with lower mean systemic Hct showed successively higher ratios 
(Figure 2B). Thus, a negative correlation was observed between systemic Hct and bluntness factor in 
both tg6 and wt mice (Figure 2C). However, despite similar Hct
 
levels of tg6 mice after hemodilution 
and wt mice prior to hemodilution, bluntness of the velocity profiles in the former group remained 
significantly higher than in the latter (Figure 2B). 
 
In Figure 3, median values of relative apparent viscosity, ηrel (symbols), estimated using 
microviscometric analysis, are plotted against the group-specific mean systemic Hct. These 
experimental data show remarkable consistency with theoretical predictions (dashed line), based on in 
vitro data for the given average vessel diameter (38 µm) and typical red cell volume of wt mice (45 fl) 
(Pries et al., 1994). The arrow in Figure 3 indicates the expected ηrel from the aforementioned in vitro 
viscosity law for the respective systemic Hct level. This extrapolation predicts that the ηrel for a 
systemic Hct of 0.85 would be approximately 3.5 fold greater than for a Hct of 0.46. 
 
Figure 4A shows the estimated tESL range for each experimental group plotted versus group-specific 
average systemic Hct. Baseline tESL in tg6 mice was 0.13 µm, which was significantly (p < 0.001) 
 lower than in wt mice (0.52 µm). After hemodilution, tESL in tg6 mice increased significantly, attaining 
a median value of 0.42 µm (p < 0.01), which is not significantly different from the baseline tESL in wt 
mice. In contrast, hemodilution of wt mice led to only a slight increase in median layer thickness (0.52 
to 0.62 µm), which did not reach significance. As indicated in Figure 4B, tESL exhibits a consistent 
inverse linear relation to the systemic Hct level, suggesting an imaginary regression line that intersects 
the abscissa (i.e. tESL = 0 µm) close to Hct 1, and the ordinate (Hct = 0) at an tESL of ~0.8 µm. 
 
Similar to the findings associated with the ESL, the width of the CFL is also inversely related to 
systemic Hct (Figure 4B). However, the relationship does not seem to be linear by nature. CFL width 
may approach a minimum value of about 0.8 µm as Hct is getting close to 1, and tends to match vessel 
radius as Hct approaches 0.  
 
 
 
 
DISCUSSION 
 
In numerous population studies, chronically elevated hematocrit is accompanied by an increase in 
total peripheral resistance, TPR, resulting in decreased cardiac output and/or increased MAP (Goubali 
et al., 1995; Schunkert et al., 2000). Similar results have also been found in animal studies 
(Richardson & Guyton, 1959; Lipowsky & Firrell, 1986). The deteriorated hemodynamic conditions, 
accompanied by reduced microvascular perfusion, and oxygen supply deficiency, are generally 
supposed to be the main risk factor for pathological, or fatal events in the cardiovasculature and 
microvasculature at elevated Hct. In addition, altered hemorheology may contribute to the increased 
risk, e.g. via disturbed microvascular blood distribution and platelet aggregation (Figure 6, left).  
 
Interestingly enough, the chronically elevated systemic Hct in tg6 mice, which is nearly twice the 
value found in wt mice (0.85 versus 0.46), is accompanied neither by a decrease in cardiac output nor 
an increase in MAP (Ruschitzka et al., 2000; Wagner et al., 2001; Vogel et al., 2003). This indicates 
that TPR (= MAP/cardiac output) is unchanged in tg6 mice relative to wt mice, suggesting the 
presence of effective hemodynamic mechanisms compensating the strongly elevated systemic Hct. 
Also, oxygen supply of both the brain and the skin in tg6 mice is not lowered relative to wt mice 
(Frietsch et al., 2007a; Frietsch et al., 2007b). In accord to this, red cell flux in post-capillary venules, 
an indicator of the potential for oxygen delivery, seems to be maintained in tg6 mice as shown in 
supplemental Figure S3. A recent study (Schuler et al., 2010) has demonstrated that the optimal 
systemic Hct (that corresponding to maximal O2 flux) during maximal exercise in tg6 mice is higher 
(0.68) than in their wt siblings (0.58), further indicating that the tg6 mice are able to adapt to this 
excessive erythrocytosis in hemodynamic terms. 
 
Several mechanisms that may reduce TPR below the actually anticipated level have been identified, 
including NO-induced increase in vessel diameter (Ruschitzka et al., 2000) and increased erythrocyte 
flexibility (Vogel et al., 2003; Bogdanova et al., 2007). 
 
A largely overlooked area that might be involved in the pathogenesis of vascular disease in 
polycythemia is the alteration of the blood–endothelium interface (Figure 6, right). A growing body of 
evidence indicates that the blood–endothelium interface comprises a ~0.5 µm thick layer (endothelial 
surface layer, ESL or glycocalyx) (Pries et al., 2000; Smith et al., 2003), which is only present in vivo 
(Potter & Damiano, 2008) and not available for free fluid flow. Our study demonstrates that the 
excessive Hct in tg6 mice is associated with a severely decreased thickness of this layer (tESL) in post-
capillary cremaster muscle venules (0.13 µm in tg6 mice versus 0.52 µm in wt mice, p < 0.001). The 
latter control value is consistent with reference values for tESL in wt mice given in the literature (Vink 
& Duling, 1996; Damiano et al., 2004; Savery & Damiano, 2008). 
 
In recent years, various conditions resulting in ESL damage, degradation or reduction have been 
identified, including the presence of reactive oxygen species (ROS) (Rubio-Gayosso et al., 2006) 
cytokines (Mulivor & Lipowsky, 2004; Potter & Damiano, 2008), oxidized low-density lipoproteins 
 (Vink et al., 2000; Constantinescu et al., 2001), and hyperglycemia (Nieuwdorp et al., 2006). Given 
the elevated eNOS levels in the endothelial cells of tg6 mice (Ruschitzka et al., 2000) the formation of 
ROS associated with NO formation could result in biochemical degradation of the ESL, as previously 
demonstrated for ischemia/reperfusion experiments (Rubio-Gayosso et al., 2006). 
 
Increased levels of hematocrit will lead to widening of the red cell column and augmented radial 
forces generated by red cell interaction. Thus, a mechanical compression of the ESL by flowing red 
cells would be the most likely cause of the reported ESL thinning in these mice. In the present study, 
the thinning of the ESL was rapidly reversible upon hemodilution to physiological levels, suggesting a 
dynamic mechanical recovery of the layer. Comparison of the cell-free layer (CFL) in tg6 with that in 
wt mice provides further support for this hypothesis (Figure 4B). The mean CFL width in tg6 mice (~1 
µm) estimated using the two-phase fluid model was found to be lesser by approximately 50% than in 
wt controls (~2 µm). Hemodilution led to a significant increase in CFL width in both tg6 and wt mice. 
The analytical methods used here thus suggest a dynamic rehydration of a mechanically compressed 
layer (rather than molecular reconstitution of a degraded layer). It has recently been shown that it can 
take up to 1 week for the ESL to fully recover after enzymatic degradation (Potter et al., 2009). 
Therefore, it seems unlikely that endothelial protein synthesis is involved in this rapid ESL thickening, 
as µ-PIV data were collected within 60 min following hemodilution. 
 
 
A decrease in tESL results in an increase in effective vessel diameter. Due to the strong inverse 
dependence of flow resistance on vessel radius, even a slight increase in vessel diameter can 
substantially decrease TPR. In light of this, we assessed the impact of tESL on flow resistance using a 
microvascular network model. Reduction in tESL in all vessels by the difference in the corresponding 
median values between tg6 mice and wt mice (i.e. by 0.4 µm), results in an ~18% decrease of network 
flow resistance, Rnet, at a Hct of 0.85 (Figure 5).  
 
A possible limitation in deriving this value may result from the uncertainty in the determination of 
individual vessel diameters while establishing the network database used. It was reported that this 
diameter determination is burdened by a relatively large error margin of about 0.5-1.0 µm (Pries et al., 
1997a). However, this error will occur in a random fashion (influencing the distribution of flow 
between vessels) while the assumed reduction of ESL thickness leads to a systematic increase of 
luminal diameter in all vessels of the network (thus influencing overall flow resistance). Thus, the 
random diameter measurement error should not have a systematic effect on the estimated change in 
overall flow resistance even if the actual error of diameter determination is higher than the ESL 
thickness or its change due to high levels of hematocrit. 
 
The estimated decrease in flow resistance due to ESL thinning is quantitatively similar to values 
reported for microinfusion of heparinase (Pries et al., 1997b) which is known to degrade the ESL.  The 
hemodynamic network simulation was used to compare this effect with those of other factors, 
including the Fåhraeus-Lindqvist (FL) effect, cell volume, and cell flexibility (Figure 5). Stepwise 
implementation of these factors leads to successive reduction in Rnet. The effect of the ESL on Rnet is 
relatively small, while the greatest reduction in Rnet results from the FL effect (Figure 5, A→B). Thus, 
the resistance changes resulting from the modification in tESL are relatively minor. 
 
The FL effect (Pries et al., 1992) takes into account the dynamic reduction of ηrel with decreasing tube 
diameter. While bulk viscosity prevails in large-diameter tubes (D≥1000 µm), values very close to 
plasma viscosity are achieved in small-diameter tubes in the capillary regime (D 5-7 µm). This 
diameter-dependent decrease in ηrel is especially strong at higher hematocrit levels, giving rise to the 
pronounced reduction in Rnet for conditions similar to those found in tg6 mice. The changes in ηrel 
described by the FL effect are dependent not only on absolute tube diameter, but more precisely, on 
the ratio of tube diameter to particle (i.e. RBC) diameter. Hence, the increase in mean corpuscular 
volume, MCV, in tg6 mice reported by Vogel et al. (2003) has the same effect as a reduced vessel 
diameter. Accordingly, an increase in MCV will generate an apparent rightward shift of the viscosity 
curve associated with a slight decrease of apparent viscosity (Figure 5, B→C).  
 
 The increased cell deformability reported in tg6 mice (Vogel et al., 2003) could also account for a 
substantial fraction in the observed reduction in TPR. Since only in vitro data are available, an attempt 
was made to integrate the reported effect on bulk viscosity, i.e. a reduction of about 50%, into our in 
vivo flow simulation. This was done by halving the RBC-dependent component of relative apparent 
viscosity (ηrel − 1) according to the equation ηreladj  =  (ηrel − 1) / 2  +  1. Since the RBC-dependent 
component of flow resistance is reduced in small vessels due to the FL effect, the resulting effect for a 
microvascular network is smaller than expected from the bulk viscosity data. A 38%-reduction in Rnet, 
relative to that obtained with baseline cell deformability, is seen for a systemic Hct of 0.85 (Figure 5, 
C→D). 
 
Taking all of these factors into account, the estimated Rnet in tg6 mice is still approximately 40% 
greater than in wt mice. This would correspond to a substantially elevated TPR for identical network 
angioarchitecture. However, our histological examinations of the extensor digitorum longus (EDL) 
muscle in tg6 mice demonstrate a 1.6-fold higher capillary density (capillary sections per area) relative 
to wt mice (p<0.001, supplemental Figure S2).  A corresponding alteration of the total number 
capillaries perfused in parallel would suggest a reduction of overall flow resistance by about 38% 
(1/1.6•100), which may compensate for the aforementioned remaining discrepancy in Rnet for identical 
network architecture. In this reasoning it is assumed that the findings for individual vessels and 
vascular beds reflect more general systematic changes. This applies to the reduction of ESL thickness 
and other microrheological parameters determined in the cremaster muscle venules and the findings of 
increased capillarization in the EDL muscle of tg6 mice. While this assumption cannot be proven 
based on the available data, it is supported by the systemic changes in TPR addressed earlier and the 
reported 2-fold increase in total blood volume of tg6 mice (Vogel et al., 2003). An increased number 
of microvessels perfused in parallel in tg6 mice would also explain the apparent discrepancy between 
the predicted systemic RBC flux (cardiac output times systemic hematocrit), which is about doubled in 
tg6 mice relative to wt mice (Vogel et al., 2003), and the microvascular RBC flux, which is not 
significantly different from wt mice (present data, supplemental Figure S3). 
 
While the hemodynamic effects of ESL thinning may be relatively small, the physiological 
implications of a change in the blood–endothelium interface due to ESL damage, degradation, or 
compression could be much more substantial. ESL thinning may evoke pathophysiological events on 
the microvascular level associated with endothelial dysfunction. Vascular pathologies related to an 
injury of the blood–endothelium interface include atherosclerosis (van den Berg et al., 2006), 
microangiopathy in diabetes (Nieuwdorp et al., 2006), tissue damage induced by ischemia-reperfusion 
(Platts et al., 2003), leukocyte recruitment and inflammation (Smith et al., 2003; Mulivor & 
Lipowsky, 2004), and altered microvascular permeability (Vink & Duling, 2000; Henry & Duling, 
2000)  (Figure 6, right).  
 
The ESL thinning that we observed allows platelets and leukocytes to come in closer proximity to the 
vessel wall, which provides those blood components with greater access to the endothelium, and may 
undermine the important barrier role of the ESL, making the vascular interface a more thrombogenic 
and proinflammatory surface than under conditions of normal hematocrit. Based on estimates of the 
stiffness of the ESL derived from several modeling studies (Damiano & Stace, 2002; Weinbaum et al., 
2003; Damiano & Stace, 2005), it is not surprising that de novo capture of leukocytes from the free 
stream is rare in post-capillary venules with an intact 500-nm-thick ESL (Smith et al., 2003). 
However, compression of the ESL to ~100–200 nm would increase the likelihood that selectin 
molecules and their receptors on the endothelium come in close proximity frequently enough to allow 
elevated adhesive interactions, more capture events from the free stream, and more leukocyte rolling. 
Thus, the ESL thinning observed in tg6 mice could lead to a more chronically inflamed state for 
microvascular endothelium. Such inflammation could, in turn, lead to the release of cytokines, and to 
increased platelet aggregation and thrombogenicity. This concept is supported by findings showing 
that the increased incidence of leukocyte adhesion and thrombosis in polycythemia vera is related to 
vascular damage and endothelial dysfunction (Neunteufl et al., 2001).  
 
Secomb et al.(Secomb et al., 2002) showed that the blood–endothelium interface plays an important 
role in buffering excessive shear stress peaks in capillaries due to wall shape irregularities. Thus, the 
 reduced tESL in tg6 mice may also lead to considerable variation in shear stress (especially if this 
reduction is due to ESL compression), giving rise to endothelial dysfunction as well as red cell 
damage. Consistent with such mechanisms, a reduced erythrocyte lifespan has been reported for tg6 
mice (Bogdanova et al., 2007). Furthermore, histological studies on elderly tg6 mice (7.2 months of 
age) have found evidence of vascular degeneration and signs of latent chronic vascular inflammation 
in the liver, the kidney and the brain (Heinicke et al., 2006; Ogunshola et al., 2006). A chronically 
compromised microvasculature and reduced red cell survival in tg6 mice could have detrimental 
effects in terms of multiple organ degeneration and may be involved in the markedly reduced life span 
of these erythrocytic animals (Wagner et al., 2001). 
 
In summary, our results show that in constitutively high hematocrit in transgenic mice, hemodynamic 
compensatory mechanisms may redress an increase in TPR that might otherwise accompany 
erythrocytosis. Hence, impaired hemodynamics is unlikely to play a significant role for the increased 
cardiovascular and microvascular risk observed in tg6 mice. However, the direct effects of 
polycythemia on the blood–endothelium interface reported in this study may have corollaries going 
beyond merely hemodynamic considerations. Excessive erthrocytosis and the accompanying 
alterations in the interaction between blood components and the vascular wall may trigger 
pathophysiological mechanisms that lead to variety of conditions directly impacting cardiovascular 
health and disease in humans with excessive erythrocytosis, such as in polcythemia vera, high-
altitude-training athletes, and blood doping.  The reduction in tESL in tg6 mice likely exerts an adverse 
impact on microvascular barrier function in terms of both water and macromolecular permeability.  
Furthermore, a reduction in tESL, together with a reduced cell-free layer, inevitiably brings platelets and 
leukocytes in close proximity to the vessel wall, which, in essence, undermines the role of the blood–
endothelium interface making it a more prothrombogenic surface relative to control conditions. The 
fact that erthrocytosis may lead to chronic thinning of the ESL by a hemodynamic mechanism (i.e. 
compressive and spontaneously reversible) provides a novel pathophysiological concept which may 
have important implications for therapeutic intervention. 
 
 REFERENCES 
 
Assaf SA, Benirschke K & Chmait RH (2011). Spontaneous twin anemia-polycythemia sequence 
complicated by recipient placental vascular thrombosis and hydrops fetalis. J Matern Fetal 
Neonatal Med 24, 549-552. 
 
Bogdanova A, Mihov D, Lutz H, Saam B, Gassmann M & Vogel J (2007). Enhanced erythro-
phagocytosis in polycythemic mice overexpressing erythropoietin. Blood 110, 762-769. 
 
Brown DW, Giles WH & Croft JB (2001). Hematocrit and the risk of coronary heart disease mortality. 
Am Heart J 142, 657-663. 
 
Constantinescu AA, Vink H & Spaan JA (2001). Elevated capillary tube hematocrit reflects 
degradation of endothelial cell glycocalyx by oxidized LDL. Am J Physiol Heart Circ Physiol 
280, H1051-1057. 
 
Damiano ER, Long DR & Smith ML (2004). Estimation of viscosity profiles using velocimetry data 
from parallel flow of linearly viscous fluids: application to microvascular haemodynamics. J 
Fluid Mech 512, 1-19. 
 
Damiano ER & Stace TM (2002). A mechano-electrochemical model of radial deformation of the 
capillary glycocalyx. Biophys J 82, 1153-1175. 
 
Damiano ER & Stace TM (2005). Flow and deformation of the capillary glycocalyx in the wake of a 
leukocyte. Physics of Fluids 17, 1153-1175. 
 
Drummond GB (2009). Reporting ethical matters in the Journal of Physiology: standards and advice. J 
Physiol 587, 713-719. 
 
Frietsch T, Gassmann M, Groth G, Waschke KF, Vogel J, Cabrales P, Vajkoczi P, Dorn-Beineke A, 
Intaglietta M & Kerger H (2007a). Excessive erythrocytosis does not elevate capillary oxygen 
delivery in subcutaneous mouse tissue. Microcirculation 14, 111-123. 
 
Frietsch T, Maurer MH, Vogel J, Gassmann M, Kuschinsky W & Waschke KF (2007b). Reduced 
cerebral blood flow but elevated cerebral glucose metabolic rate in erythropoietin 
overexpressing transgenic mice with excessive erythrocytosis. J Cereb Blood Flow Metab 27, 
469-476. 
 
Gagnon DR, Zhang TJ, Brand FN & Kannel WB (1994). Hematocrit and the risk of cardiovascular 
disease--the Framingham study: a 34-year follow-up. Am Heart J 127, 674-682. 
 
Goubali A, Voukiklaris G, Kritsikis S, Viliotou F & Stamatis D (1995). Relation of hematocrit values 
to coronary heart disease, arterial hypertension, and respiratory impairment in occupational 
and population groups of the Athens area. Angiology 46, 719-725. 
 
Harrison MJ, Pollock S, Kendall BE & Marshall J (1981). Effect of haematocrit on carotid stenosis 
and cerebral infarction. Lancet 2, 114-115. 
 
Heinicke K, Baum O, Ogunshola OO, Vogel J, Stallmach T, Wolfer DP, Keller S, Weber K, Wagner 
PD, Gassmann M & Djonov V (2006). Excessive erythrocytosis in adult mice overexpressing 
erythropoietin leads to hepatic, renal, neuronal, and muscular degeneration. Am J Physiol 
Regul Integr Comp Physiol 291, R947-956. 
 
Henry CB & Duling BR (2000). TNF-alpha increases entry of macromolecules into luminal 
endothelial cell glycocalyx. Am J Physiol Heart Circ Physiol 279, H2815-2823. 
 
 Jelkmann W (2011). Regulation of erythropoietin production. J Physiol 589, 1251-1258. 
 
Kim S, Kong RL, Popel AS, Intaglietta M & Johnson PC (2007). Temporal and spatial variations of 
cell-free layer width in arterioles. Am J Physiol Heart Circ Physiol 293, H1526-1535. 
 
Lipowsky HH & Firrell JC (1986). Microvascular hemodynamics during systemic hemodilution and 
hemoconcentration. Am J Physiol 250, H908-922. 
 
Long DS, Smith ML, Pries AR, Ley K & Damiano ER (2004). Microviscometry reveals reduced 
blood viscosity and altered shear rate and shear stress profiles in microvessels after 
hemodilution. Proc Natl Acad Sci U S A 101, 10060-10065. 
 
Lowe GD & Forbes CD (1985). Platelet aggregation, haematocrit, and fibrinogen. Lancet 1, 395-396. 
 
Maeda N, Suzuki Y, Tanaka J & Tateishi N (1996). Erythrocyte flow and elasticity of microvessels 
evaluated by marginal cell-free layer and flow resistance. Am J Physiol 271, H2454-2461. 
 
Mulivor AW & Lipowsky HH (2004). Inflammation- and ischemia-induced shedding of venular 
glycocalyx. Am J Physiol Heart Circ Physiol 286, H1672-1680. 
 
Neunteufl T, Heher S, Stefenelli T, Pabinger I & Gisslinger H (2001). Endothelial dysfunction in 
patients with polycythaemia vera. Br J Haematol 115, 354-359. 
 
Nieuwdorp M, van Haeften TW, Gouverneur MC, Mooij HL, van Lieshout MH, Levi M, Meijers JC, 
Holleman F, Hoekstra JB, Vink H, Kastelein JJ & Stroes ES (2006). Loss of endothelial 
glycocalyx during acute hyperglycemia coincides with endothelial dysfunction and 
coagulation activation in vivo. Diabetes 55, 480-486. 
 
Ogunshola OO, Djonov V, Staudt R, Vogel J & Gassmann M (2006). Chronic excessive 
erythrocytosis induces endothelial activation and damage in mouse brain. Am J Physiol Regul 
Integr Comp Physiol 290, R678-684. 
 
Platts SH, Linden J & Duling BR (2003). Rapid modification of the glycocalyx caused by ischemia-
reperfusion is inhibited by adenosine A2A receptor activation. Am J Physiol Heart Circ 
Physiol 284, H2360-2367. 
 
Potter DR & Damiano ER (2008). The hydrodynamically relevant endothelial cell glycocalyx 
observed in vivo is absent in vitro. Circ Res 102, 770-776. 
 
Potter DR, Jiang J & Damiano ER (2009). The recovery time course of the endothelial cell glycocalyx 
in vivo and its implications in vitro. Circ Res 104, 1318-1325. 
 
Pries AR, Neuhaus D & Gaehtgens P (1992). Blood viscosity in tube flow: dependence on diameter 
and hematocrit. Am J Physiol 263, H1770-1778. 
 
Pries AR, Schonfeld D, Gaehtgens P, Kiani MF & Cokelet GR (1997a). Diameter variability and 
microvascular flow resistance. Am J Physiol 272, H2716-2725. 
 
Pries AR & Secomb TW (2005). Microvascular blood viscosity in vivo and the endothelial surface 
layer. Am J Physiol Heart Circ Physiol 289, H2657-2664. 
 
Pries AR, Secomb TW & Gaehtgens P (2000). The endothelial surface layer. Pflugers Arch 440, 653-
666. 
 
Pries AR, Secomb TW, Gessner T, Sperandio MB, Gross JF & Gaehtgens P (1994). Resistance to 
blood flow in microvessels in vivo. Circ Res 75, 904-915. 
  
Pries AR, Secomb TW, Jacobs H, Sperandio M, Osterloh K & Gaehtgens P (1997b). Microvascular 
blood flow resistance: role of endothelial surface layer. Am J Physiol 273, H2272-2279. 
 
Reitsma S, Slaaf DW, Vink H, van Zandvoort MA & oude Egbrink MG (2007). The endothelial 
glycocalyx: composition, functions, and visualization. Pflugers Arch 454, 345-359. 
 
Richardson TQ & Guyton AC (1959). Effects of polycythemia and anemia on cardiac output and other 
circulatory factors. Am J Physiol 197, 1167-1170. 
 
Rubio-Gayosso I, Platts SH & Duling BR (2006). Reactive oxygen species mediate modification of 
glycocalyx during ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 290, H2247-
2256. 
 
Ruschitzka FT, Wenger RH, Stallmach T, Quaschning T, de Wit C, Wagner K, Labugger R, Kelm M, 
Noll G, Rulicke T, Shaw S, Lindberg RL, Rodenwaldt B, Lutz H, Bauer C, Luscher TF & 
Gassmann M (2000). Nitric oxide prevents cardiovascular disease and determines survival in 
polyglobulic mice overexpressing erythropoietin. Proc Natl Acad Sci U S A 97, 11609-11613. 
 
Savery MD & Damiano ER (2008). The endothelial glycocalyx is hydrodynamically relevant in 
arterioles throughout the cardiac cycle. Biophys J 95, 1439-1447. 
 
Schuler B, Arras M, Keller S, Rettich A, Lundby C, Vogel J & Gassmann M (2010). Optimal 
hematocrit for maximal exercise performance in acute and chronic erythropoietin-treated 
mice. Proc Natl Acad Sci U S A 107, 419-423. 
 
Schunkert H, Koenig W, Brockel U, Muscholl MW, Doring A, Riegger GA & Hense HW (2000). 
Haematocrit profoundly affects left ventricular diastolic filling as assessed by Doppler 
echocardiography. J Hypertens 18, 1483-1489. 
 
Secomb TW, Hsu R & Pries AR (2002). Blood flow and red blood cell deformation in nonuniform 
capillaries: effects of the endothelial surface layer. Microcirculation 9, 189-196. 
 
Skretteberg PT, Bodegard J, Kjeldsen SE, Erikssen G, Thaulow E, Sandvik L & Erikssen JE (2010). 
Interaction between inflammation and blood viscosity predicts cardiovascular mortality. Scand 
Cardiovasc J 44, 107-112. 
 
Smith ML, Long DS, Damiano ER & Ley K (2003). Near-wall micro-PIV reveals a hydrodynamically 
relevant endothelial surface layer in venules in vivo. Biophys J 85, 637-645. 
 
Spivak JL (2002). Polycythemia vera: myths, mechanisms, and management. Blood 100, 4272-4290. 
 
Suwaidi JA, Hamasaki S, Higano ST, Nishimura RA, Holmes DR, Jr. & Lerman A (2000). Long-term 
follow-up of patients with mild coronary artery disease and endothelial dysfunction. 
Circulation 101, 948-954. 
 
van den Berg BM, Spaan JA, Rolf TM & Vink H (2006). Atherogenic region and diet diminish 
glycocalyx dimension and increase intima-to-media ratios at murine carotid artery bifurcation. 
Am J Physiol Heart Circ Physiol 290, H915-920. 
 
Vink H, Constantinescu AA & Spaan JA (2000). Oxidized lipoproteins degrade the endothelial surface 
layer : implications for platelet-endothelial cell adhesion. Circulation 101, 1500-1502. 
 
Vink H & Duling BR (1996). Identification of distinct luminal domains for macromolecules, 
erythrocytes, and leukocytes within mammalian capillaries. Circ Res 79, 581-589. 
 
 Vink H & Duling BR (2000). Capillary endothelial surface layer selectively reduces plasma solute 
distribution volume. Am J Physiol Heart Circ Physiol 278, H285-289. 
 
Vogel J & Gassmann M (2011). Erythropoietic and non-erythropoietic functions of erythropoietin 
(Epo) in mouse models. J Physiol 589, 1259-1264. 
 
Vogel J, Kiessling I, Heinicke K, Stallmach T, Ossent P, Vogel O, Aulmann M, Frietsch T, Schmid-
Schonbein H, Kuschinsky W & Gassmann M (2003). Transgenic mice overexpressing 
erythropoietin adapt to excessive erythrocytosis by regulating blood viscosity. Blood 102, 
2278-2284. 
 
Wagner KF, Katschinski DM, Hasegawa J, Schumacher D, Meller B, Gembruch U, Schramm U, 
Jelkmann W, Gassmann M & Fandrey J (2001). Chronic inborn erythrocytosis leads to cardiac 
dysfunction and premature death in mice overexpressing erythropoietin. Blood 97, 536-542. 
 
Wannamethee G, Perry IJ & Shaper AG (1994). Haematocrit, hypertension and risk of stroke. J Intern 
Med 235, 163-168. 
 
Weinbaum S, Zhang X, Han Y, Vink H & Cowin SC (2003). Mechanotransduction and flow across 
the endothelial glycocalyx. Proc Natl Acad Sci U S A 100, 7988-7995. 
 
 
 
 AUTHOR CONTRIBUTIONS 
 
V.R. contributed to conception and design of the experiments, analysis and interpretation of the 
results, drafting of the article, and revised the article critically for important intellectual content; 
M.D.S. contributed to analysis and interpretation of the results, and drafting of the article; M.G. 
generated the tg6 mouse line, contributed to drafting of the article, and helped revising the article; 
O.B. contributed to analysis and interpretation of the results, and drafting of the article; E.R.D. 
contributed to conception and design of the experiments, analysis and interpretation of the results, 
drafting of the article, and revised the article critically for important intellectual content; and A.R.P. 
contributed to conception and design of the experiments, analysis and interpretation of the results, 
drafting of the article, and revised the article critically for important intellectual content. 
 
All authors have approved the final version for publication. 
 
All experiments for his study were conducted in the laboratories of the Dept of Physiology 
Charité Berlin, Berlin, Germany. 
 
 
ACKNOWLEDGEMENTS 
 
Partial support for this work was provided by the National Institutes of Health, grant R01 HL076499 
(E.R.D.) and by a graduate fellowship from the Clare Boothe Luce Foundation (M.D.S.). 
 
 TABLES 
 
Table 1. Cardiovascular and microvascular flow parameters of tg6 mice and wt mice both before and 
after isovolemic hemodilution. 
 
 tg85 tg50 wt46 wt27 
MAP (mmHg) 77 ± 5 52 ± 3 69 ± 2 60 ± 7 
HR (beats/min) 342 ± 21 525 ± 37 261 ± 18 330 ± 21 
centerline velocity (µm/s) 1182 ± 99 2317 ± 234 3422 ± 425 3856 ± 503 
average flow velocity (µm/s) 786 ± 66 1464 ± 144 2054 ± 262 2149 ± 284 
vmax/vmean 1.51  ± 0.02 1.58 ± 0.03 1.68 ± 0.02 1.81 ± 0.01 
pressure gradient  
(103 dyn/cm3) -9.0 ± 1.1 -12.2 ± 1.5 -17.7 ± 1.8 -15.0 ± 2.0 
flow rate (nl/s) 1.1 ± 0.1 2.3 ± 0.4 2.3 ± 0.4 2.2 ± 0.3 
mean shear rate (s-1) 63 ± 6 115 ± 12 203 ± 22 222 ± 25 
interfacial shear rate (s-1) 646 ± 63 956 ± 111 1212 ± 130 1012 ± 126 
interfacial  shear stress 
(dyn/cm2) - 12.0 ± 7.2 15.5 ± 9.9 12.9 ± 9.4 
relative apparent viscosity - 2.50 ± 0.1 2.06 ± 0.1 1.6 ± 0.1 
ESL thickness (µm) 0.15 ± 0.03 [0.13] 
0.45 ± 0.06 
[0.42] 
0.47 ± 0.04 
[0.52] 
0.58 ± 0.04 
[0.62] 
CFL thickness (µm) 1.1 ± 0.1 [0.9] 
1.7 ± 0.2 
[1.3] 
1.8 ± 0.2 
[1.6] 
2.8 ± 0.3 
[2.4] 
Interfacial shear rate and interfacial shear stress refer to the blood-ESL interface, at the luminal ESL 
surface. Values are expressed as mean ± SE. Figures in square brackets represent median values. 
 FIGURES AND LEGENDS 
 
 
 
Figure 1. Measurements and concept of microvascular blood flow. A, Photomicrograph of a 
venule (45.5 µm in diameter). White encircled dots represent the dual image of a microsphere. 
Arrowheads denote the opposing sides of the inner vessel wall. The x/y/z-coordinates of the vessel 
section and the time signal superimpose the video signal at its upper edge. B, Schematic illustration of 
the fluid layers adjacent to the luminal aspect of endothelial cells (ECs). While actual flow conditions 
(left-hand side) suggest a continuous reduction of local hematocrit towards the ESL – vessel lumen 
interface, the idealized two-phase flow model (right-hand side) assumes an instantaneous transition 
between regions of maximum Hct (RBC-core) and regions of zero Hct (cell-free layer, CFL). The 
endothelial surface layer (ESL) is considered consistently as a distinct, nearly quiescent fluid layer.  
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Figure 2. Microhemodynamic parameters in post-capillary cremaster muscle venules. A, 
Average flow velocity. B, Averaged velocity profiles for each group. Each profile is normalized to the 
radial position of the blood-ESL interface (vessel radius−tESL) and to the centerline velocity, vmax. The 
dotted curve indicates a velocity profile of parabolic shape. The box-plot (inset) shows the ratio of vmax 
to vmean as a metric for the degree of bluntness of the velocity profiles. A value of 2 corresponds to a 
perfectly parabolic shape of the velocity profile, while a smaller value corresponds to a rather blunt 
profile. C, Dependence of the ratio vmax/vmean on systemic Hct in tg6 mice (black symbols) and wt mice 
(gray symbols), before (circles) and after hemodilution (rhombs). n.s. not significant; *, p<0.05; **, 
p<0.01; ***, p<0.001; r2, coefficient of determination. 
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Figure 3. Dependence of the relative apparent viscosity on systemic Hct. Symbols represent 
median values of the respective group as a whole, and were estimated using microviscometric 
analysis. The dashed curve is derived from the in vitro viscosity law (Pries et al., 1994), assuming the 
experimental mean vessel diameter (38 µm) and the typical red cell volume of wt mice (45 fl). The 
arrow indicates the expected relative apparent viscosity for tg6 mice, obtained by extrapolation of the 
non-linear fit to glass tube data (Pries et al., 1992) to a systemic Hct of 0.85. 
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Figure 4. Dimensions of the near-wall fluid layers. Estimated thickness of the ESL (A) and 
estimated width of the CFL (B) as a function of systemic hematocrit. Each symbol represents the mean 
± SE of the respective group as a whole. The arrows in panel A denote the corresponding median 
values (see also Table 1), which are referred to in Fig 5. 
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Figure 5. Overall flow resistance of a microvascular network. Dependence of flow resistance in an 
experimental microvascular network on ESL thickness (I-III) and systemic hematocrit (0.27, 0.46 and 
0.85). In addition, four other factors are considered. 
A:  Bulk viscosity is assumed for all vessels independent of vessel diameter. 
B:  Reduction of apparent viscosity with declining vessel diameter according to Fåhraeus-Lindqvist 
effect is taken into account. 
C:  Effect of increased red cell volume, MCV, is included (wt 45 fl vs. tg6 57 fl). 
D:  Impact of increased cell flexibility on bulk viscosity according to Vogel et al. (2003) is 
integrated. 
Values are normalized to the flow resistance obtained for wt mice under spontaneous conditions (ESL 
thickness II, systemic Hct 0.46, MCV 45 fl, normal cell flexibility). Each column in light gray 
represents the predicted flow resistance of the considered experimental group (tg85, wt46, wt27) if the 
assumed parameters are applied to it. Categories of ESL thickness (I-III) correspond to the group-
specific median values rounded to one decimal place. 
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Figure 6. Impact of elevated Hct on cardiovascular risk, possible role of compensatory 
mechanisms and alterations of blood–endothelium interface. 
Left, conventional concept: Increased Hct leads to increased viscosity (right branch) which causes 
increased total peripheral resistance (TPR) and thus increased mean arterial pressure (MAP), reduced 
blood flow, and reduced oxygen supply. In addition, the modified microrheological properties of the 
blood (left branch) may lead to increased heterogeneity of local perfusion. Both effects could 
contribute to the reported increase in cardiovascular risk. 
Right, present concept: In chronic hematocrit elevation in tg6 mice, a number of compensatory 
mechanisms are activated. The reported increases in cell flexibility and cell volume counteract the 
increase in effective blood viscosity in microvessels (right branch). Similarly, the increase in total 
intravascular volume also reduces TPR at a given viscosity. The reduction of glycocalyx/ESL 
thickness reduces TPR, but this effect is relatively limited (~18%). These compensatory mechanisms 
taken together, restore TPR to levels similar to wild-type controls, despite the excessive increase in 
Hct. However, the increased red cell concentration also compromises the blood–endothelium interface 
and reduces the ESL thickness (middle branch). This may have strong biological effects on the blood–
endothelium interface contributing to the known cardiovascular risks associated with polycythemia. 
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